Literature DB >> 22178270

Transcriptional regulation of miR-224 upregulated in human HCCs by NFκB inflammatory pathways.

Cecilia Scisciani1, Stefania Vossio, Francesca Guerrieri, Valeria Schinzari, Rossana De Iaco, Paolo D'Onorio de Meo, Melchiorre Cervello, Giuseppe Montalto, Teresa Pollicino, Giovanni Raimondo, Massimo Levrero, Natalia Pediconi.   

Abstract

BACKGROUND & AIMS: miR-224 is up-regulated in human HCCs as compared to both paired peri-tumoral cirrhotic tissues and cirrhotic livers without HCC. Here, we have cloned the miR-224 regulatory region and characterized its transcriptional regulation by the NFκB-dependent inflammatory pathways.
METHODS: Mature miRNA expression was evaluated by a 2 step stem-loop real-time RT-PCR. The recruitment of polymerase II and transcription factors on the pre-miR-224 promoter has been assessed by ChIPSeq and ChIP.
RESULTS: We found miR-224 levels strongly up-regulated in both peri-tumoral cirrhotic livers and HCC samples as compared to normal livers. In silico analysis of the putative miR-224 promoter revealed multiple NFκB sites. We showed that LTα and TNFα activate transcription from the miR-224 promoter and of endogenous miR-224 expression in HCC cell lines, whereas the expression of miR-224 target API5 was reduced. Exogenously expressed p65/RelA activates the miR-224 promoter and a dominant negative form of IκBα (IκBSR) represses it. ChIP analysis showed that p65/NFκB is recruited on the miR-224 promoter and that its binding sharply increases after exposure to LPS, TNFα, and LTα. Altogether these findings link the inflammatory signals to NFκB-mediated activation of miR-224 expression. An antago-miR specific for miR-224 blocked LPS and LTα stimulated HCC cells migration and invasion. Conversely, the IKK inhibitor BMS-345541 blocks pre-miR-224-induced cellular migration and invasion.
CONCLUSIONS: Our results identify p65/NFκB as a direct transcriptional regulator of miR-224 expression and link miR-224 up-regulation with the activation of the LPS, LTα, and TNFα inflammatory pathways and cell migration/invasion in HCC. Copyright Â
© 2011 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22178270     DOI: 10.1016/j.jhep.2011.11.017

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  64 in total

Review 1.  Epigenetics of hepatocellular carcinoma: role of microRNA.

Authors:  Sharad Khare; Qiong Zhang; Jamal A Ibdah
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

Review 2.  The role of microRNAs in hepatocarcinogenesis: current knowledge and future prospects.

Authors:  Motoyuki Otsuka; Takahiro Kishikawa; Takeshi Yoshikawa; Motoko Ohno; Akemi Takata; Chikako Shibata; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2013-11-21       Impact factor: 7.527

3.  The MicroRNA-224 Inhibitor Prevents Neuronal Apoptosis via Targeting Spastic Paraplegia 7 After Cerebral Ischemia.

Authors:  Feng Fu; Dingfeng Wu; Chao Qian
Journal:  J Mol Neurosci       Date:  2016-05-10       Impact factor: 3.444

Review 4.  Role of miRNA and its potential as a novel diagnostic biomarker in drug-induced liver injury.

Authors:  Sukumaran Sanjay; Chandrashekaran Girish
Journal:  Eur J Clin Pharmacol       Date:  2016-12-27       Impact factor: 2.953

5.  The Effect of miR-98 and miR-214 on Apoptotic and Angiogenic Pathways in Hepatocellular Carcinoma HepG2 Cells.

Authors:  Shaymaa M M Yahya; Shereen M M Yahya
Journal:  Indian J Clin Biochem       Date:  2019-03-11

6.  Circulating microRNA predicts insensitivity to glucocorticoid therapy in Graves' ophthalmopathy.

Authors:  Liyun Shen; Fengjiao Huang; Lei Ye; Wei Zhu; Xiaofang Zhang; Shu Wang; Weiqing Wang; Guang Ning
Journal:  Endocrine       Date:  2015-01-15       Impact factor: 3.633

7.  E2F1 induces miR-224/452 expression to drive EMT through TXNIP downregulation.

Authors:  Susanne Knoll; Katharina Fürst; Bhavani Kowtharapu; Ulf Schmitz; Stephan Marquardt; Olaf Wolkenhauer; Hubert Martin; Brigitte M Pützer
Journal:  EMBO Rep       Date:  2014-10-23       Impact factor: 8.807

8.  MicroRNA expression might predict prognosis of epithelial hepatoblastoma.

Authors:  Mónika Gyugos; Gábor Lendvai; István Kenessey; Krisztina Schlachter; Judit Halász; Péter Nagy; Miklós Garami; Zsuzsa Jakab; Zsuzsa Schaff; András Kiss
Journal:  Virchows Arch       Date:  2014-02-26       Impact factor: 4.064

Review 9.  MicroRNA-224: as a potential target for miR-based therapy of cancer.

Authors:  Wei Chen; Xue-Mei Fan; Ling Mao; Jun-Ying Zhang; Jian Li; Jian-Zhong Wu; Jin-Hai Tang
Journal:  Tumour Biol       Date:  2015-08-08

10.  Expression of miR-92a, miR-224 and miR-25 in non-small cell lung cancer and their correlation with clinical characteristics.

Authors:  Hao Yuan; Jiajia Su; Siqin Hu; Peng Wei
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.